glp-1 ra drugs list Market Overview: Agonists and the Obesity Market | Blog List of injectable GLP-1RA agents

July 2, 2025: Study Shows Zepbound Patients Typically Take GLP-1 Drug Over a Year According to a new study highlighted by Reuters, over 60 percent of patients who started Zepbound last year were still taking the weight loss and diabetes drug this year

And they did find the gene for glucagon, and they were surprised to discover that the same gene that makes glucagon also makes two other small peptides

Understanding the Current GLP-1 Landscape and Why Alternatives Are Being Sought The weight management medication market has changed dramatically since semaglutide-based treatments gained wide attention

As insulin doses are reduced to prevent hypoglycemia, there is also a potential risk of hyperglycemia and eliciting diabetic ketoacidosis

Lien et al., 2014)

doi: 10.2337/db08-0307